IGKV1D-22 and Cerebral ischemia: Thus it is conceivable, but not proven, that soluble S100A8/A9 contributes to the blood-brain barrier disturbances during cerebral ischemia by stimulating local recruitment of additional leukocytes and induction of cytokine release (Wang et al., 2018).